Biswas Swati, Zhang Suhong, Fernandez Fernando, Ghosh Balaram, Zhen Juan, Kuzhikandathil Eldo, Reith Maarten E A, Dutta Aloke K
Department of Pharmaceutical Sciences, Wayne State University, Detroit, Michigan 48202, USA.
J Med Chem. 2008 Jan 10;51(1):101-17. doi: 10.1021/jm070860r. Epub 2007 Dec 12.
This paper describes an extended structure-activity relationships study of aminotetralin-piperazine-based hybrid molecules developed earlier for dopamine D2/D3 receptors. Various analogues as positional isomers have been developed where location of the phenolic hydroxyl group has been varied on the aromatic ring. Between two catechol derivatives, compound 6e with a two methylene linker length exhibited higher affinity and selectivity for D3 over D2 receptors over compound 6f with four methylene linkers (D2/D3 = 50.6 vs 7.51 for 6e and 6f, respectively). In general, the (-)-isomer was more potent than the (+)-isomeric counterpart. Binding results indicated highest selectivity for D3 receptors in compound (-)- 10 ( K i = 0.35 nM; D2/D3 = 71). In the 5-hydroxy series, highest selectivity for D3 receptors was exhibited by compound (-)- 25 ( K i = 0.82 nM; D2/D3 = 31.5). Most potent compounds exhibited binding and functional affinities at the sub-nanomolar level for the D3 receptor. Binding assays were carried out with HEK-293 cells expressing either D2 or D3 receptors by using tritiated spiperone as radioligand for competition studies to evaluate inhibition constants ( K i). A functional assay of selected compounds for stimulating GTPgammaS binding was carried out with CHO cells expressing human D2 receptors and AtT-20 cells expressing human D3 receptors. The functional assay results indicated partial to full agonist characteristics of test compounds. Compound (-)- 25 was selected further for in vivo study to evaluate its potency in producing contralateral rotations in rats with unilateral lesion in the nigrostriatal region induced by neurotoxin 6-OHDA, a Parkinsonian animal model. Compound (-)- 25 at 5 micromol/kg exhibited rotational activity that lasted beyond 12 h, whereas at a 1 micromol/kg dose the rotations lasted beyond 8 h.
本文描述了一项针对早期开发的基于氨基四氢萘 - 哌嗪的杂化分子与多巴胺D2/D3受体的扩展构效关系研究。已开发出各种作为位置异构体的类似物,其中酚羟基在芳环上的位置有所变化。在两种儿茶酚衍生物之间,具有两个亚甲基连接长度的化合物6e对D3受体的亲和力和选择性高于具有四个亚甲基连接的化合物6f(6e和6f的D2/D3分别为50.6和7.51)。一般来说,(-)-异构体比(+)-异构体更具活性。结合结果表明化合物(-)-10对D3受体具有最高的选择性(Ki = 0.35 nM;D2/D3 = 71)。在5-羟基系列中,化合物(-)-25对D3受体表现出最高的选择性(Ki = 0.82 nM;D2/D3 = 31.5)。大多数活性化合物对D3受体的结合亲和力和功能亲和力在亚纳摩尔水平。通过使用氚化螺哌隆作为放射性配体进行竞争研究,以评估抑制常数(Ki),对表达D2或D3受体的HEK-293细胞进行结合测定。对选定化合物刺激GTPγS结合的功能测定是在表达人D2受体的CHO细胞和表达人D3受体的AtT-20细胞上进行的。功能测定结果表明测试化合物具有部分至完全激动剂特性。进一步选择化合物(-)-25进行体内研究,以评估其在帕金森病动物模型(由神经毒素6-OHDA诱导黑质纹状体区域单侧损伤的大鼠)中产生对侧旋转的效力。化合物(-)-25以5微摩尔/千克的剂量表现出持续超过12小时的旋转活性,而在1微摩尔/千克的剂量下,旋转持续超过8小时。